Astrana Health, Inc.

NASDAQ:ASTH

Medical - Care Facilities

Healthcare
$29.65 +2.70%

+$1.03 today

Market cap
$1.47B
Beta
0.94
P/E (TTM)
63.3
EPS (TTM)
$0.62
52W Low $18.08High $40.13

Volume 0.52M

Average 0.51M

ASTH Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Astrana Health, Inc.NASDAQ: ASTH

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income growth accelerates

Q1 FY2026 net income of $14.44M rose 132.1% year over year, ahead of the -26.6% change in trailing-twelve-month net income. Sequentially, it rose 120.0% from the prior quarter. Over 3 fiscal years it compounded at -19.3% a year.

Context

  • Net income amounted to 0.8% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 8 analysts of $61.88M (+157.0%) for the fiscal year ending Dec 2026, a step up from the -51.8% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.44M+120.0% QoQ
Last fiscal yearDec 2025
$24.08M-51.8% YoY
LTMMar 2026
$32.29M-26.6% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+132.1%+64.1%-68.0 pp
1 year-51.8%+157.0%+208.8 pp
3-year CAGR-19.3%+69.1%+88.4 pp
5-year CAGR+50.5%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
24.08M USD
Year-over-year change
-51.8%
4-year CAGR
-15.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How ASTH compares with its peers on the latest reported figures

  • ASTH's LTM Mar 2026 net income of $32.29M is the 3rd largest of the 4 companies compared; the peer median is $28.12M.
  • Its year-over-year change of -26.6% is the lowest of 4, against a peer median of +41.1%.
  • Net income amounts to 0.9% of revenue for ASTH, versus a peer median of 6.1%.
ASTH Competitors Peer median
Net Income for ASTH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AGLAgilon Health, Inc.LTM Mar 2026$354.54M +41.1%+54.1%6.1%
NUTXNutex Health, Inc.LTM Mar 2026$187.54M +33.9%—21.3%
ASTHAstrana Health, Inc.LTM Mar 2026$32.29M -26.6%-19.3%0.9%
PRVAPrivia Health Group, Inc.LTM Jun 2026$28.12M +71.4%—1.2%
Peer median (excluding ASTH) $28.12M+41.1%+54.1%6.1%

Competitors are the stored peer set for ASTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income46.06M45.74M57.85M49.93M24.08M
Depreciation & Amortization17.52M17.54M17.75M27.93M45.75M
Deferred Income Tax7.67M(14.28M)(12.44M)(4.25M)(4.29M)
Stock-Based Compensation6.75M16.1M22.04M34.54M38.6M
Change in Working Capital(33.64M)(1.96M)(23.39M)(63.61M)(3.1M)
Accounts Receivables(21.63M)(33.97M)(20.57M)(11.1M)(7.16M)
Inventory(2.11M)27.61M12.16M00
Accounts Payables4.11M(2.52M)(498K)(30.43M)(11.69M)
Other Working Capital(14.01M)6.92M(14.48M)(22.09M)15.76M
Other Non-Cash Items25.99M18.98M6.42M7.67M13.56M
Operating Cash Flow70.34M82.13M68.23M52.2M114.6M
Capital Expenditures(19.22M)(22.94M)(28.53M)(8.03M)(10.11M)
Acquisitions (Net)(3.91M)(18.46M)(7.54M)(156.14M)(548.6M)
Purchases of Investments(28M)(1.85M)(6.15M)(2.61M)0
Sales of Investments67.61M31.67M491K124K15.1M
Other Investing Activities56K4.47M(23.8M)(25.74M)4.61M
Investing Cash Flow16.54M(7.11M)(65.52M)(192.4M)(539M)
Debt Repayment(58.69M)(828K)79.17M152.71M604.81M
Common Stock Issued40.13M0000
Common Stock Repurchased(5.74M)(9.25M)(10.19M)(937K)(15.43M)
Dividends Paid(31.09M)(14.03M)(62.07M)(4.04M)(7.89M)
Other Financing Activities(1.42M)4.02M(5.01M)(12.59M)(12.15M)
Financing Cash Flow(47.75M)(20.09M)3.42M135.15M569.35M
Effect of Forex Changes00000
Net Change in Cash39.13M54.93M6.13M(5.05M)144.94M
Free Cash Flow51.11M59.19M39.7M44.17M104.49M

Astrana Health, Inc.

NASDAQ:ASTH

Intrinsic Alpha fair value

Locked

Current Price

$29.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.